Department of Psychiatry, University of British Columbia, Canada
Correspondence: Dr Peter F. Liddle, Department of Psychiatry, University of British Columbia, 2255 Westbrook Mall, Vancouver BC, V6T 2AI, Canada; e-mail: liddle{at}interchange.ubc.ca
Declaration of interest Supported in part by the Norma Calder Foundation.
Background Functional imaging studies indicate that delusions and hallucinations in schizophrenia are associated with overactivity of the left hippocampus and ventral striatum. Hippocampal neuronal firing modulates feedback to cortex via corticostriatothalamic loops.
Aims To test the hypothesis that recovery from psychosis is associated with decrease in activity in corticostriatothalamic circuits, and, furthermore, that reduction in hippocampal activity predicts the degree of alleviation of delusions and hallucinations.
Method Positron emission tomography (PET) was used to measure the effects of the atypical antipsychotic, risperidone, on glucose metabolism in eight first-episode schizophrenia patients.
Results A single dose of risperidone produced decreases in metabolism in ventral striatum, thalamus and frontal cortex. The magnitude of decreases in left hippocampus predicted subsequent reduction in delusions and hallucinations. After six weeks' treatment with risperidone, the decreases in frontal metabolism were more extensive.
Conclusions The mechanism of antipsychotic action of risperidone entails reduction of hippocampal activity together with reduced feedback via corticostriatothalamic loops.
This article has been cited by other articles:
![]() |
D. Dickinson and P. D. Harvey Systemic Hypotheses for Generalized Cognitive Deficits in Schizophrenia: A New Take on An Old Problem Schizophr Bull, March 1, 2009; 35(2): 403 - 414. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. KESHAVAN, G. BERGER, R. B. ZIPURSKY, S. J. WOOD, and C. PANTELIS Neurobiology of early psychosis The British Journal of Psychiatry, August 1, 2005; 187(48): s8 - s18. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Lang, L. C. Kopala, R. A. Vandorpe, Q. Rui, G. N. Smith, V. M. Goghari, J. S. Lapointe, and W. G. Honer Reduced Basal Ganglia Volumes After Switching to Olanzapine in Chronically Treated Patients With Schizophrenia Am J Psychiatry, October 1, 2004; 161(10): 1829 - 1836. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M.R. Prasad, A. R. Patel, S. Muddasani, J. Sweeney, and M. S. Keshavan The Entorhinal Cortex in First-Episode Psychotic Disorders: A Structural Magnetic Resonance Imaging Study Am J Psychiatry, September 1, 2004; 161(9): 1612 - 1619. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Hazlett, M. S. Buchsbaum, E. Kemether, R. Bloom, J. Platholi, A. M. Brickman, L. Shihabuddin, C. Tang, and W. Byne Abnormal Glucose Metabolism in the Mediodorsal Nucleus of the Thalamus in Schizophrenia Am J Psychiatry, February 1, 2004; 161(2): 305 - 314. [Abstract] [Full Text] [PDF] |
||||
![]() |
E T C Ngan, C J Lane, T J Ruth, and P F Liddle Immediate and delayed effects of risperidone on cerebral metabolism in neuroleptic naive schizophrenic patients: correlations with symptom change J. Neurol. Neurosurg. Psychiatry, January 1, 2002; 72(1): 106 - 110. [Abstract] [Full Text] [PDF] |
||||